These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20167095)

  • 1. Keratin 19 marks poor differentiation and a more aggressive behaviour in canine and human hepatocellular tumours.
    van Sprundel RG; van den Ingh TS; Desmet VJ; Katoonizadeh A; Penning LC; Rothuizen J; Roskams T; Spee B
    Comp Hepatol; 2010 Feb; 9(1):4. PubMed ID: 20167095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of multidrug resistance-associated protein 1 in hepatocellular carcinoma is associated with a more aggressive tumour phenotype and may reflect a progenitor cell origin.
    Vander Borght S; Komuta M; Libbrecht L; Katoonizadeh A; Aerts R; Dymarkowski S; Verslype C; Nevens F; Roskams T
    Liver Int; 2008 Dec; 28(10):1370-80. PubMed ID: 19055643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular characteristics of keratin 19-positive canine hepatocellular tumours explain its aggressive behaviour.
    van Sprundel RG; van den Ingh TS; Schotanus BA; van Wolferen ME; Penning LC; Rothuizen J; Spee B
    Vet Rec Open; 2017; 4(1):e000212. PubMed ID: 29118993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of Epigenetic and Epithelial Mesenchymal Transition Marks in Hepatocellular Carcinoma with Keratin 19 Proficiency.
    Yokomichi N; Nishida N; Umeda Y; Taniguchi F; Yasui K; Toshima T; Mori Y; Nyuya A; Tanaka T; Yamada T; Yagi T; Fujiwara T; Yamaguchi Y; Goel A; Kudo M; Nagasaka T
    Liver Cancer; 2019 Jul; 8(4):239-254. PubMed ID: 31602368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of K19 and K7 in dysplastic nodules and hepatocellular carcinoma.
    Bae JS; Choi HN; Noh SJ; Park BH; Jang KY; Park CK; Moon WS
    Oncol Lett; 2012 Aug; 4(2):213-220. PubMed ID: 22844356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification of primary hepatic tumours in the dog.
    van Sprundel RG; van den Ingh TS; Guscetti F; Kershaw O; Kanemoto H; van Gils HM; Rothuizen J; Roskams T; Spee B
    Vet J; 2013 Sep; 197(3):596-606. PubMed ID: 24011584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keratin 19: a key role player in the invasion of human hepatocellular carcinomas.
    Govaere O; Komuta M; Berkers J; Spee B; Janssen C; de Luca F; Katoonizadeh A; Wouters J; van Kempen LC; Durnez A; Verslype C; De Kock J; Rogiers V; van Grunsven LA; Topal B; Pirenne J; Vankelecom H; Nevens F; van den Oord J; Pinzani M; Roskams T
    Gut; 2014 Apr; 63(4):674-85. PubMed ID: 23958557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis.
    Kim H; Choi GH; Na DC; Ahn EY; Kim GI; Lee JE; Cho JY; Yoo JE; Choi JS; Park YN
    Hepatology; 2011 Nov; 54(5):1707-17. PubMed ID: 22045674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinico-Radio-Pathological and Molecular Features of Hepatocellular Carcinomas with Keratin 19 Expression.
    Rhee H; Kim H; Park YN
    Liver Cancer; 2020 Dec; 9(6):663-681. PubMed ID: 33442539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinomas in captive prosimians.
    Robveille C; Cullen JM
    Vet Pathol; 2022 Nov; 59(6):1012-1021. PubMed ID: 35876312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin.
    Komuta M; Spee B; Vander Borght S; De Vos R; Verslype C; Aerts R; Yano H; Suzuki T; Matsuda M; Fujii H; Desmet VJ; Kojiro M; Roskams T
    Hepatology; 2008 May; 47(5):1544-56. PubMed ID: 18393293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of Yes-associated protein 1 in hepatocellular carcinoma with stemness and combined hepatocellular-cholangiocarcinoma.
    Kim GJ; Kim H; Park YN
    PLoS One; 2013; 8(9):e75449. PubMed ID: 24086533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung and lymph node metastases from hepatocellular carcinoma: Comparison of pathological aspects.
    Woo HY; Rhee H; Yoo JE; Kim SH; Choi GH; Kim DY; Woo HG; Lee HS; Park YN
    Liver Int; 2022 Jan; 42(1):199-209. PubMed ID: 34490997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming acidic coiled-coil-containing protein 3 (TACC3) overexpression in hepatocellular carcinomas is associated with "stemness" and epithelial-mesenchymal transition-related marker expression and a poor prognosis.
    Nahm JH; Kim H; Lee H; Cho JY; Choi YR; Yoon YS; Han HS; Park YN
    Tumour Biol; 2016 Jan; 37(1):393-403. PubMed ID: 26219896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour epithelial and stromal characteristics of hepatocellular carcinomas with abundant fibrous stroma: fibrolamellar versus scirrhous hepatocellular carcinoma.
    Kim YJ; Rhee H; Yoo JE; Alves VAF; Kim GJ; Kim HM; Herman P; Chagas A; Kim H; Park YN
    Histopathology; 2017 Aug; 71(2):217-226. PubMed ID: 28326574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification of primary hepatic tumours in the cat.
    van Sprundel RG; van den Ingh TS; Guscetti F; Kershaw O; van Wolferen ME; Rothuizen J; Spee B
    Vet J; 2014 Nov; 202(2):255-66. PubMed ID: 25439443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Keratin 19-expressing hepatocellular carcinoma and small-duct type intrahepatic cholangiocarcinoma show a similar postoperative clinical course but have distinct genetic features.
    Akita M; Ajiki T; Fukumoto T; Itoh T; Zen Y
    Histopathology; 2019 Sep; 75(3):385-393. PubMed ID: 31017316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of arginase-1, keratin (K) 8 and K18 in combined hepatocellular-cholangiocarcinoma, subtypes with stem-cell features, intermediate-cell type.
    Akiba J; Nakashima O; Hattori S; Naito Y; Kusano H; Kondo R; Nakayama M; Tanikawa K; Todoroki K; Umeno Y; Nakamura K; Sanada S; Yamaguchi R; Ogasawara S; Yano H
    J Clin Pathol; 2016 Oct; 69(10):846-51. PubMed ID: 26969740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BSEP and MDR3: Useful Immunohistochemical Markers to Discriminate Hepatocellular Carcinomas From Intrahepatic Cholangiocarcinomas and Hepatoid Carcinomas.
    Fujikura K; Yamasaki T; Otani K; Kanzawa M; Fukumoto T; Ku Y; Hirose T; Itoh T; Zen Y
    Am J Surg Pathol; 2016 May; 40(5):689-96. PubMed ID: 26735860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Keratin 19, a Cancer Stem Cell Marker in Human Hepatocellular Carcinoma.
    Kawai T; Yasuchika K; Ishii T; Katayama H; Yoshitoshi EY; Ogiso S; Kita S; Yasuda K; Fukumitsu K; Mizumoto M; Hatano E; Uemoto S
    Clin Cancer Res; 2015 Jul; 21(13):3081-91. PubMed ID: 25820415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.